Cancer News and Research

Latest Cancer News and Research

Research on immune system sets stage for novel approach to cancer immunotherapy

Basic research into the dual nature of certain immune system cells has set the stage for a new approach to cancer immunotherapy that avoids some of the shortcomings associated with other methods, scientists at Dana-Farber Cancer Institute report in a new study in the Proceedings of the National Academy of Sciences.

17 May 2016

Minority, less educated women believe breast cancer is common killer than heart disease

According to recent studies, the U.S. has a disadvantage in women's life expectancy compared to peer countries despite high rates of health screenings such as mammography and popular national awareness campaigns.

17 May 2016

Motor protein Myo1c uses actin cytoskeleton as 'track' for Neph1 transport

The motor protein Myo1c binds to Neph1, a protein crucial for ensuring effective filtration by the kidney, and serves as one mode of its cellular transport, according to findings by investigators at the Medical University of South Carolina and their collaborators reported in the May 16, 2016 issue of Molecular and Cellular Biology.

17 May 2016

Novel therapeutic approach to treat leukaemia patients

Cancer cells have an abnormal cell division and survival machinery - they grow faster than they die. For their permanent development, they produce an excess of growth factors and nutrients and block the body's own safety mechanisms.

17 May 2016

Phase 2 results of AbbVie’s venetoclax in patients with R/R CLL with 17p deletion published in The Lancet Oncology

AbbVie, a global biopharmaceutical company, today announced The Lancet Oncology published results from the Phase 2, single arm, open label trial studying venetoclax in patients with relapsed/refractory (R/R) chronic lymphocytic leukaemia (CLL) with 17p deletion.

17 May 2016

Could worm infection counter IBD? An interview with Dr Loke and Dr Cadwell

The hygiene hypothesis refers to the idea that decreased exposure to certain infectious agents (because of better hygiene) is the reason why we have seen an increase in inflammatory diseases in the developed world.

17 May 2016

Diets rich in fruits and vegetables can help prevent chronic inflammation

A new study by the University of Liverpool's Institute of Ageing and Chronic Disease has identified food stuffs that can help prevent chronic inflammation that contributes to many leading causes of death.

17 May 2016

Lightpoint Medical signs exclusive global license agreement with UA for Beta Emission Tomography

Lightpoint Medical, a clinical-stage medical device company developing advanced imaging technologies for intraoperative cancer detection, announced today that the company has signed an exclusive global license agreement for a molecular imaging technology called Beta Emission Tomography, developed by Professor Harrison Barrett, Regents Professor of Radiology and Optical Science, with his student Yijun Ding and colleague Dr. Luca Caucci at the University of Arizona Center for Gamma Ray Imaging.

17 May 2016

Researchers reveal new mechanism that helps breast cancer cells engage MDSCs

Not every breast cancer tumor follows the same path to grow. Some tumors have the assistance of myeloid-derived suppressor cells (MDSCs), a diverse type of immune cell involved in the suppression of the body's response against tumors.

17 May 2016

Study shows inhibition of SHP-2 enzyme can diminish lupus symptoms

Researchers at Beth Israel Deaconess Medical Center have identified an enzyme that is significantly elevated in mouse models of systemic lupus erythematosus and in blood samples of patients with lupus.

17 May 2016

Carol Fabian inducted into KU Women's Hall of Fame for contributions to breast cancer research

Among the women inducted into the University of Kansas Hall of Fame on April 14, 2016, was Carol Fabian, MD. Fabian, a professor of medicine at the University of Kansas Medical Center and director of the Breast Cancer Prevention Center at The University of Kansas Cancer Center, is a nationally recognized oncologist and a pioneer in in the field of breast cancer research.

17 May 2016

FDA approves additional indication for Eisai's anticancer agent Lenvima in combo with Everolimus for advanced renal cell carcinoma

Eisai Co., Ltd. has announced that its U.S. subsidiary Eisai Inc. has received approval from the U.S. Food and Drug Administration (FDA) for an additional indication for Eisai's in-house developed novel anticancer agent Lenvima (lenvatinib mesylate) in combination with everolimus for the treatment of patients with advanced renal cell carcinoma following one prior anti-angiogenic therapy.

16 May 2016

Ipsen partners with IMCB to advance understanding and research of Botulinum Neurotoxin Biology

Ipsen S.A., a global specialty-driven pharmaceutical company, and the Institute of Molecular and Cell Biology (IMCB), a research institute under the aegis of the Agency for Science, Technology and Research (A*STAR), Singapore, today announced the signature of a research partnership to study the intracellular trafficking of botulinum neurotoxins (BoNTs) within neurons.

16 May 2016

DeNovix honored at Scientists’ Choice Awards® Best New Life Sciences Product 2015

DeNovix’s DS-11 FX+ Series of Spectrophotometers / Fluorometers was awarded runner-up position in the annual Scientists Choice Awards® Best New Life Sciences Product 2015. The award was presented during this year’s American Association for Cancer Research (AACR) annual meeting.

16 May 2016

Unlocking the dark proteome: an interview with Dr Kriwacki

The term dark proteome refers to proteins whose structural features and thus functions are not well understood. Many proteins within the dark proteome do not fold into stable three-dimensional structures. These proteins are called intrinsically disordered proteins (IDPs) and feature highly flexible, disordered confirmations.

16 May 2016

Genomic cfDNA profiling feasible in metastatic CRPC

Comprehensive genomic profiling of cell-free DNA can provide clinically useful information in men with castration-resistant prostate cancer treated with enzalutamide, research indicates.

14 May 2016

Altered coagulation caused by HIV virus linked to increased risk of non-AIDS diseases

With more than 36.9 million people infected globally, HIV continues to be a major public health issue. Those living with the virus are at an increased risk for other non-AIDS diseases, such as cardiovascular disease and cancer, and though it's not entirely clear why, this has been associated with inflammation and abnormal blood clotting.

13 May 2016

TSRI chemists identify and design potent therapeutic ‘warheads’ for different diseases

In a pair of related studies, chemists from the Florida campus of The Scripps Research Institute (TSRI) have identified and designed dozens of molecular “warheads” that not only can detect a key biomarker of cancer, but also could be developed into a potent new class of drug candidates for a range of diseases.

13 May 2016

WHO: Air pollution levels increase in low- and middle income cities

More than 80% of people living in urban areas that monitor air pollution are exposed to air quality levels that exceed the World Health Organization limits. While all regions of the world are affected, populations in low-income cities are the most impacted.

13 May 2016

Lack of UV protection in car windows may contribute to increased cancer rates

A recent analysis of the glass in car windows has shown that front windshields consistently provide a high level of ultraviolet (UV) protection whereas the UV protection afforded by side windows was much lower and more variable. Drivers who frequently make long journeys may thus be unwittingly exposing themselves to damaging UV rays.

13 May 2016

Cancer News and Research

Latest Cancer News and Research

Research on immune system sets stage for novel approach to cancer immunotherapy

Minority, less educated women believe breast cancer is common killer than heart disease

Motor protein Myo1c uses actin cytoskeleton as 'track' for Neph1 transport

Novel therapeutic approach to treat leukaemia patients

Phase 2 results of AbbVie’s venetoclax in patients with R/R CLL with 17p deletion published in The Lancet Oncology

Could worm infection counter IBD? An interview with Dr Loke and Dr Cadwell

Diets rich in fruits and vegetables can help prevent chronic inflammation

Lightpoint Medical signs exclusive global license agreement with UA for Beta Emission Tomography

Researchers reveal new mechanism that helps breast cancer cells engage MDSCs

Study shows inhibition of SHP-2 enzyme can diminish lupus symptoms

Carol Fabian inducted into KU Women's Hall of Fame for contributions to breast cancer research

FDA approves additional indication for Eisai's anticancer agent Lenvima in combo with Everolimus for advanced renal cell carcinoma

Ipsen partners with IMCB to advance understanding and research of Botulinum Neurotoxin Biology

DeNovix honored at Scientists’ Choice Awards® Best New Life Sciences Product 2015

Unlocking the dark proteome: an interview with Dr Kriwacki

Genomic cfDNA profiling feasible in metastatic CRPC

Altered coagulation caused by HIV virus linked to increased risk of non-AIDS diseases

TSRI chemists identify and design potent therapeutic ‘warheads’ for different diseases

WHO: Air pollution levels increase in low- and middle income cities

Lack of UV protection in car windows may contribute to increased cancer rates

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in